Bad Medicine, Again: Bush Stem Cell Veto All Wrong
In a dubious historic achievement, the Bush White House has now twice exercised its veto over a bill that was twice passed with bipartisan majorities in both houses of Congress—once when Congress was controlled by Republicans, once when controlled by Democrats. The bill that would make more stem cell lines eligible for federal research funding is supported by a solid majority of Americans in every survey and by every major medical research organization and university in the country.
Even the president’s own director of the National Institutes of Health, Dr. Elias Zerhouni, told the Senate that, due to Bush administration policy, scientists in the
The administration cites an ethical objection to research that would involve the destruction of human embryos. Yet surely the administration knows that by federal rules no tax dollars can be used to destroy embryos, only to conduct research using the potent cells that come from them. And surely the administration also knows that the embryos would come from fertility clinics with no chance of being implanted into a woman, and with full informed consent of the couple, and no money changing hands.
This White House believes itself to be in a better position to judge what should be done with these stem cells than the men and women who donate them.
White House officials may protest that recent scientific papers present other possible cell sources. Yet not a single scientist who is pursuing research on any kind of cell has said that research involving embryonic stem cells should stop. On the contrary, because scientists know well that a single approach is unlikely to provide a universal solution, they are as one in advocating funding from all sources and for all types of stem cell research.
Embryonic stem cell research will continue in spite of this veto, but it will have to be done largely without federal funds, which are by far the largest single source of research support in the world. And it will be done in other countries. Years from now Nobel prizes for breakthroughs in the use of stem cells may be awarded to scientists only just beginning their careers. Unfortunately, those awards could go to those getting started on this research outside of the
That is a question the American people deserve to have answered.
Jonathan D. Moreno, Ph.D., is the David and Lyn Silfen University Professor and Professor of Medical Ethics and the History and Sociology of Science at the University of Pennsylvania and a Senior Fellow at the Center for American Progress.
Sam Berger is a Researcher at the Center for American Progress.
For more information, please see:
- Divided We Fail: The Need for National Stem Cell Funding
- HOPE is not Enough
- Embryonic Stem Cell Research by the Numbers
To speak with our experts on this topic, please contact:
Print: Liz Bartolomeo (poverty, health care)
202.481.8151 or firstname.lastname@example.org
Print: Tom Caiazza (foreign policy, energy and environment, LGBT issues, gun-violence prevention)
202.481.7141 or email@example.com
Print: Allison Preiss (economy, education)
202.478.6331 or firstname.lastname@example.org
Print: Tanya Arditi (immigration, Progress 2050, race issues, demographics, criminal justice, Legal Progress)
202.741.6258 or email@example.com
Print: Chelsea Kiene (women's issues, TalkPoverty.org, faith)
202.478.5328 or firstname.lastname@example.org
Print: Benton Strong (Center for American Progress Action Fund)
202.481.8142 or email@example.com
Spanish-language and ethnic media: Jennifer Molina
202.796.9706 or firstname.lastname@example.org
TV: Rachel Rosen
202.483.2675 or email@example.com
Radio: Sally Tucker
202.482.8103 or firstname.lastname@example.org